Zim Laboratories Limited — Board Meeting, 07-08-2025: Outcome of Board Meeting
07-08-2025 | 07:52 pm
07-08-2025 | 07:52 pm
ZIM Laboratories' board approved Q1 FY25 consolidated financials, showing ₹71.76 Cr revenue and a ₹1.87 Cr net loss. Strategically, the board greenlit an investment of up to AED 4,50,000 into ZIM Scientific Office L.L.C. to expand GCC business. They also decided to close ZIM Laboratories Middle East DMCC. Protiviti India was appointed Internal Auditor for FY25-26. #ZIMLAB #BoardMeeting
No comments yet. Be the first to comment!
